Filter
1355
Text search:
pharmaceutical
policies
Featured
Recommendations
122
New Publications
370
Language
Document type
No document type
676
Studies & Reports
300
Guidelines
188
Strategic & Response Plan
80
Manuals
60
Training Material
15
Situation Updates
12
Fact sheets
12
Resource Platforms
6
Brochures
3
Infographics
3
Countries / Regions
Kenya
63
Global
59
Ethiopia
55
India
42
South Africa
36
Nigeria
35
Western and Central Europe
32
Uganda
31
Sierra Leone
27
Namibia
25
Ghana
23
Tanzania
22
Liberia
21
Malawi
21
Africa
20
Nepal
19
Zambia
19
Rwanda
18
Ukraine
18
Bangladesh
17
Eastern Europe
15
Indonesia
14
Latin America and the Carribbean
14
Zimbabwe
13
Lesotho
13
Philippines
12
Syria
11
South–East Asia Region
11
Cambodia
10
Myanmar / Burma
9
West and Central Africa
9
Congo, Democratic Republic of
7
Eswatini/ Swaziland
7
Botswana
7
East and Southern Africa
7
Asia
6
Senegal
5
Cameroon
5
Germany
5
Thailand
5
Middle East and North Africa
5
Burkina Faso
4
Haiti
4
Pakistan
4
South Sudan
4
Mozambique
4
Eastern Europe and Central Asia
4
Venezuela
4
Albania
4
Vietnam
4
Afghanistan
3
Benin
3
Brazil
3
Western Pacific Region
3
Laos
3
Guinea
2
Mali
2
USA
2
Jordan
2
Egypt
2
China
2
Sudan
2
Peru
2
Fiji
2
Lithuania
2
North America
2
Saudi Arabia
1
Niger
1
Iraq
1
Lebanon
1
Chad
1
Ireland
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
North Macedonia
1
El Salvador
1
Angola
1
Sri Lanka
1
Chile
1
Mongolia
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Romania
1
Iran
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
597
Clinical Guidelines
73
Public Health
64
Key Resources
61
Women & Child Health
31
Pharmacy & Technologies
20
Capacity Building
11
Toolboxes
AMR
160
COVID-19
104
Pharmacy
102
TB
73
Mental Health
69
HIV
64
Planetary Health
34
NCDs
32
NTDs
31
Rapid Response
28
Global Health Education
26
Health Financing Toolbox
23
Conflict
22
Caregiver
22
Malaria
14
2.0 Rapid Response
13
Ebola & Marburg
11
Refugee
9
Disability
7
Natural Hazards
5
Polio
4
Zika
4
Cholera
3
Specific Hazards
3
Social Ethics
1
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
he National Department of Health (NDOH) presents this Malaria Elimination Strategic
Plan 2019-2023 for the Republic of South Africa. The strategy comes at an important time
as the Southern African Development Community (SADC) heads of state have recently
renewed the commitment to eliminate malari
...
Economic Issues, Policies and Option for Action
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multis
...
Mental health issues are usually given very low priority in health service policies. Although this is changing, African countries are still confronted with so many problems caused by communicable diseases and malnutrition that they have not woken up
...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Th
...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF
...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedi
...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO
...
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for anti
...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain manag
...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regi
...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at differ
...
This guideline aims to improve the quality of donations and the management thereof and serve as the basis for policies of the State and other organizations in the giving and receiving of donations of medicines, medical devices and IVDs.
Over the
...
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o ...
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o ...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the NMCP and with the participation of national and international partners involved in
...
